Fresenius SE & Co. KGaA (FRE.DE)

29,46 +0,16 (+0,55%) Al cierre: 05:35PM CEST

Fresenius SE & Co. KGaA

Else-Kroener-Strasse 1
Bad Homburg vor der Höhe 61352
Germany
49 6172 6080
https://www.fresenius.com

Sector(es): Healthcare
Sector: Medical Care Facilities
Empleados a tiempo completo: 315.233

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Michael Sen	CEO, Pres & Chairman of Management Board - Fresenius Management SE	2,91M	N/A	1968
Ms. Sara Lisa Hennicken	CFO & Member of the Management Board - Fresenius Management SE	919k	N/A	1980
Dr. Sebastian Biedenkopf	Chief Legal Officer, HR, Labor Relations Director, Risk Mgmt & Member of Mgmt. Board	1,51M	N/A	1964
Ms. Helen Giza	Member of the Management Board - Fresenius Management SE	1,98M	N/A	1968
Mr. Pierluigi Antonelli	Member of Management Board of Fresenius Management SE & CEO of Fresenius Kabi	N/A	N/A	N/A
Dr. Michael Sven Moser Ph.D.	Member of Management Board of Fresenius Management SE	N/A	N/A	1977
Mr. Robert Moller	Member of the Management Board of Fresenius Management SE	N/A	N/A	1970
Mr. Markus Georgi	Sr. VP of Investor Relations	N/A	N/A	N/A
Matthias Link	Sr. VP Corp. Communications	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Gobierno corporativo

El ISS Governance QualityScore de Fresenius SE & Co. KGaA, a día 28 de septiembre de 2023, es 1. Las puntuaciones base son Auditoría: 1; Tablero: 3; Derechos de los accionistas: 1; Compensación: 1.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.